Patent classifications
C03C2201/3423
DOPED BISMUTH SILICATE CRYSTALS VIA DEVITRIFICATION OF GLASS FORMING LIQUIDS
This technology is directed to the preparation of doped-bismuth-silicate seed crystals through controlled crystallization (e.g. dimensionality of growth and nucleation mechanism) and the method of forming high purity single seed (particle size ranges from micrometers to millimeters) for various uses. These seed crystals have a nominal stoichiometry of Bi.sub.2-xA.sub.xSiO.sub.5, Bi.sub.2-xA.sub.xSi.sub.3O.sub.9, Bi.sub.4-xA.sub.xSi.sub.3O.sub.9, and Bi.sub.12-xA.sub.xSiO.sub.20, where A is a rare earth dopant selected from La, Ce, Nd, Pr, and/or Sm.
MISERITE CRYSTALLIZED GLASS FOR ARTIFICIAL TOOTH AND METHOD FOR COLORING SAME
Disclosed are a miserite crystallized glass for an artificial tooth and a method for coloring same, the method enabling a production of a uniform shade without degrading the physical properties of a crystallized glass by means of simply adding a small amount of coloring additive powder when preparing the crystallized glass. A miserite crystallized glass for an artificial tooth according to the present invention is colored with any one of the shades in groups A, B, C and D of the Vita shade guide which is a tooth shade reference. The miserite crystallized glass has a miserite crystal phase as the main phase and comprises a hydroxyapatite crystal phase and a xonotlite crystal phase as additional phases.
Glass fiber composition, glass fiber and composite material therefrom
The present invention provides a glass fiber composition, glass fiber and composite material therefrom. The glass fiber composition comprises the following components expressed as percentage by weight: 58-63% SiO.sub.2, 13-17% Al.sub.2O.sub.3, 6-11.8% CaO, 7-11% MgO, 3.05-8% SrO, 0.1-2% Na.sub.2O+K.sub.2O+Li.sub.2O, 0.1-1% Fe.sub.2O.sub.3, 0-1% CeO.sub.2 and 0-2% TiO.sub.2, wherein a weight percentage ratio C1=(MgO+SrO)/CaO is greater than 1. Said composition greatly improves the refractive index of glass, significantly shields against harmful rays for humans and further reduces glass crystallization risk and production costs, thereby making it more suitable for large-scale production with refractory-lined furnaces.
WOLLASTONITE CRYSTALLIZED GLASS FOR ARTIFICIAL TOOTH AND METHOD FOR COLORING SAME
Disclosed are a wollastonite crystallized glass for an artificial tooth and a method for coloring same, the method enabling a production of a uniform shade without degrading the physical properties of a crystallized glass by means of simply adding a small amount of coloring additive powder when preparing the crystallized glass.
Radiation-resistant laser optical fiber preform core rod and preparation method therefor
A radiation-resistant laser optical fiber preform core rod at least includes one type of activated ion (Yb.sup.3+, Er.sup.3+) and one or more types of co-doped ion (Al.sup.3+, P.sup.5+, Ge.sup.4+, Ce.sup.3+, F.sup.?), and OD group of 16-118 ppm. Irradiation resistance of core rod glass can be effectively improved by sequentially performing pre-treatments, i.e. deuterium loading, pre-irradiation and thermal annealing on a preform core rod. Electron paramagnetic resonance test shows that, under the same radiation condition, the radiation induced color center concentration in a preform core rod treated by the method above is lower than in an untreated core rod by one or more orders of magnitude. The obtained core rod can be used for preparing a radiation-resistant rare earth-doped silica fiber, and has the advantages of high laser slope efficiency, low background loss, being able to be used stably in a vacuum environment for a long time, for example.
WAVELENGTH CONVERSION MEMBER, AND LIGHT EMITTING DEVICE USING SAME
Provided is a wavelength conversion member that is less decreased in luminescence intensity with time by irradiation with light of an LED or LD and a light emitting device using the wavelength conversion member. A wavelength conversion member is formed of an inorganic phosphor dispersed in a glass matrix, wherein the glass matrix contains, in % by mole, 30 to 85% SiO.sub.2, 0 to 20% B.sub.2O.sub.3, 0 to 25% Al.sub.2O.sub.3, 0 to 3% Li.sub.2O, 0 to 3% Na.sub.2O, 0 to 3% K.sub.2O, 0 to 3% Li.sub.2O+Na.sub.2O+K.sub.2O, 0 to 35% MgO, 0 to 35% CaO, 0 to 35% SrO, 0 to 35% BaO, 0.1 to 45% MgO+CaO+SrO+BaO, and 0 to 4% ZnO, and the inorganic phosphor is at least one selected from the group consisting of an oxide phosphor, a nitride phosphor, an oxynitride phosphor, a chloride phosphor, an oxychloride phosphor, a halide phosphor, an aluminate phosphor, and a halophosphoric acid chloride phosphor.
GLASS FIBER COMPOSITION, GLASS FIBER AND COMPOSITE MATERIAL THEREFROM
The present invention provides a glass fiber composition, glass fiber and composite material therefrom. The glass fiber composition comprises the following components expressed as percentage by weight: 58-63% SiO.sub.2, 13-17% Al.sub.2O.sub.3, 6-11.8% CaO, 7-11% MgO, 3.05-8% SrO, 0.1-2% Na.sub.2O+K.sub.2O+Li.sub.2O, 0.1-1% Fe.sub.2O.sub.3, 0-1% CeO.sub.2 and 0-2% TiO.sub.2, wherein a weight percentage ratio C1=(MgO+SrO)/CaO is greater than 1. Said composition greatly improves the refractive index of glass, significantly shields against harmful rays for humans and further reduces glass crystallization risk and production costs, thereby making it more suitable for large-scale production with refractory-lined furnaces.
Fused quartz tubing for pharmaceutical packaging
A high silica glass composition comprising about 92 to about 99.9999 wt. % SiO.sub.2 and from about 0.0001 to about 8 wt. % of at least one dopant selected from Al.sub.2O.sub.3, CeO.sub.2, TiO.sub.2, La.sub.2O.sub.3, Y.sub.2O.sub.3, Nd.sub.2O.sub.3, other rare earth oxides, and mixtures of two or more thereof. The glass composition has a working point temperature ranging from 600 to 2,000 C. These compositions exhibit stability similar to pure fused quartz, but have a moderate working temperature to enable cost effective fabrication of pharmaceutical packages. The glass is particularly useful as a packaging material for pharmaceutical applications, such as, for example pre-filled syringes, ampoules and vials.